Ceros Financial Services’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Ceros Financial Services’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$46K	Buy	+1,099	New	+$44.7K	0.01%	154

Other funds holding XPH

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

Ceros Financial Services's XPH Position: Q1 2019 in Review

Ceros Financial Services opened a new position in State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2019: 1,099 shares worth $46K. The stake represents 0.01% of the portfolio and ranks #154 among its holdings.

80 funds tracked by Wall St. Rank hold XPH as of Q1 2019.

Ceros Financial Services held 1,099 shares of State Street SPDR S&P Pharmaceuticals ETF worth $46K as of Q1 2019.
State Street SPDR S&P Pharmaceuticals ETF was a new Ceros Financial Services position in Q1 2019.
State Street SPDR S&P Pharmaceuticals ETF made up 0.01% of Ceros Financial Services's portfolio in Q1 2019, its #154 holding.
80 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2019.

Based on Ceros Financial Services's 13F filing for Q1 2019, filed 3 May 2019.